|
Adasheva T.V., Samorukova E.I., Gubernatorova E.E., Lobanova E.G., Shahrai N.B.
Anticoagulant therapy for non-valvular atrial fibrillation patients with CHA2DS2-VASC score 1 (regardless of gender): A personalized approach based on risk/benefit analysis
|
№4 / 2023
|
|
Kislyak O.A., Mikaelyan A.A., Starodubova A.V., Kosyura S.D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
|
№3 / 2023
|
|
Malyshenko O.S., Taskina E.A., Raskina T.A., Averkieva Yu.V., Usova E.V., Koroleva M.V., Letaeva M.V.
Evaluation of safety of bioactive concentrate of small marine fish in senile patients with knee osteoarthritis and high comorbidity rates
|
№3 / 2023
|
|
Mubarakshina O.A., Batishcheva G.A., Shcherbova Z.R.
Use of magnesium and sulfates enriched natural mineral water in case of functional constipations in adult and pediatric patients
|
№2 / 2023
|
|
Ovchinnikov A.Yu., Akopyan L.V., Yegiyan S.S.
The choice of the method of cerumenolysis and prevention of sulfur plugs formation
|
№2 / 2023
|
|
Berns S.A.
Antibacterial therapy as an interdisciplinary problem in patients with rhinosinusitis
|
№2 / 2023
|
|
E.A. Strebkova, L.I. Alekseeva
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases
|
№2 / 2023
|
|
Golovatyuk A.O., Kochetkov A.I., Ostroumova T.M., Ostroumova O.D., Poluektov M.G.
Insomnia as a comorbid disorder
|
№2 / 2023
|
|
Gazdanova A.A., Plieva A.S., Solovieva S.A., Ponomarenko T.M.
Examination of the oral cavity as an important diagnostic tool of a primary care physician
|
№2 / 2023
|
|
Malyavin A.G., Martynov A.I., Gorelov A.V., Lioznov D.A., Esaulenko E.V., Pshenichnaya N.Yu., Bolieva L.Z, Gurov A.V., Karneeva O.V., Babak S.L.
Resolution of the Expert Council on the use of herbal medicines for respiratory infections
|
№2 / 2023
|
|
Zakharov V.V., Ostroumova O.D., Kochetkov A.I., Klepikova M.V., Fedin A.I.
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension
|
№1 / 2023
|
|
Mazurov V.I., Bashkinov R.A., Inamova O.V., Petrova M.S., Morozova K.P.
Therapy of osteoarthritis in combination with asymptomatic hyperuricemia: results of a pilot study
|
№1 / 2023
|
Русский
